Metlife Inc. buy Morgan Stanley
Summary
This prediction ended on 14.04.24 with a price of €66.56. The prediction had a final performance of 23.01%. Morgan_Stanley has a follow-up prediction for Metlife Inc. where he still thinks Metlife Inc. is a Buy. Dividends of €1.91 are taken into consideration when calculating the performance. Morgan_Stanley has 50% into this predictionMetLife Inc. (Symbol: MET) (WKN: 934623) is a globally renowned insurance, annuities, and employee benefits company, founded in 1868, with its headquarters in New York City. As a leading player in the financial services sector, this Fortune 500 company offers a comprehensive range of products and services, including life insurance, dental and vision coverage, accident and health insurance, retirement and savings solutions, and more. Boasting a diverse clientele, MetLife serves individual customers, SMEs, and large-scale corporations across the globe, with a strong focus on enhancing value for its shareholders, policyholders, and clients. With an underlying commitment to innovation and customer-centric strategies, this publicly traded company (NYSA: MET) has established its presence in more than 40 countries, continuing to expand its horizons in the changing dynamics of global demographics and financial security needs.
Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Metlife Inc. | 1.846% | 1.846% | 25.565% |
iShares Core DAX® | 1.308% | 1.167% | 25.330% |
iShares Nasdaq 100 | -0.156% | 1.246% | 27.119% |
iShares Nikkei 225® | 1.270% | 0.293% | 18.646% |
iShares S&P 500 | 0.476% | 1.292% | 27.786% |
Comments by Morgan_Stanley for this prediction
In the thread Metlife Inc. diskutieren
In the thread Trading Metlife Inc.